Research

We study the epidemiology, clinical burden, economic impact, and prevention of pneumococcal disease across diverse populations.

We generate real-world evidence on the burden, outcomes, and prevention of respiratory syncytial virus disease across pediatric and adult populations, with particular attention to high-risk groups and healthcare utilization.

We examine the burden and geographic distribution of sarcoidosis, with a focus on healthcare utilization, treatment patterns, and patient outcomes.

We evaluate vaccine effectiveness, safety, uptake, and policy-relevant outcomes to support evidence-based immunization strategies.

We assess the economic burden, healthcare costs, resource utilization, and value of prevention and treatment strategies.

We investigate the short- and long-term cardiorespiratory complications associated with infectious diseases and other health conditions.

Our work in maternal–child health uses real-world data to examine health outcomes and care patterns among pregnant individuals, postpartum patients, infants, and children, with the goal of informing prevention and improving health across generations.